More rigour needed in trials of new diagnostic agents for tuberculosis

被引：47

作者：

Small, PM ^{[1
]}

Perkins, MD

机构：

[1] Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA

[2] WHO, CH-1211 Geneva, Switzerland

来源：

关键词：

D O I：

10.1016/S0140-6736(00)02724-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1048 / 1049

页数：2

共 9 条

[1]

Foulds J, 1998, INT J TUBERC LUNG D, V2, P778

[2]

*GLOB TUB CONTR, 2000, WHO REP 2000

RANSOHOFF, DF ;

FEINSTEIN, AR .

REID, MC ;

LACHS, MS ;

FEINSTEIN, AR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (08) :645-651

[5]

Somi GR, 1999, INT J TUBERC LUNG D, V3, P231

[6]

Tsubura E, 1997, Kekkaku, V72, P611

[7]

*US FOOD DRUG ADM, 2000, REV CRIT ASS IN VITR

[8] GUIDELINES FOR THE ASSESSMENT OF NEW DIAGNOSTIC-TESTS [J].

VANDERSCHOUW, YT ;

VERBEEK, ALM ;

RUIJS, SHJ .

[9]

*WHO, 2000, WHO WORKSH TUB DIAB